Literature DB >> 25563679

Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma.

Julien Perrin1, François Depasse2, Thomas Lecompte3.   

Abstract

BACKGROUND: Calibrated Automated Thrombography (CAT) has been widely used to assess in vitro thrombin generation as an informative intermediary phenotype of coagulation. Interlaboratory exercises have documented a worrisome poor reproducibility. There are some data on the normalisation with an appropriate external reference plasma (RP). This multicentre study of the French-speaking CAT Club aimed at providing further evidence for the usefulness of such a normalisation.
MATERIALS AND METHODS: Lyophilised aliquots of a RP along with 3 plasmas (P1=normal; P2=hypo-; P3=hypercoagulable) were sent to 34 laboratories (corresponding to 38 instruments). CAT was studied using 1 and 5 pM tissue factor and other dedicated reagents. Normalisation with the local RP in use in the laboratory could also be performed. Interlaboratory CVs were calculated for each plasma before and after normalisation.
RESULTS: Regarding endogenous thrombin potential, a good discrimination between the 3 plasmas was achieved in all laboratories but there was no overlap after normalisation only. CVs were generally not reduced with the use of local RP but were generally improved with normalisation using the external RP, often becoming lower than 10%. Regarding P2 however, the benefit of normalisation was poor, and there were analytical difficulties as well, some laboratories being unable to get a useable signal.
CONCLUSIONS: We confirm that normalisation of CAT results with a suitable external RP is useful in "real life" practice as it often permits an acceptable level of interlaboratory variability. In case of frank hypocoagulability, further improvements are required to get reliable, potentially clinically relevant results.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Normalisation; Reference plasma; Standardisation; Thrombin generation tests

Mesh:

Substances:

Year:  2014        PMID: 25563679     DOI: 10.1016/j.thromres.2014.12.015

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  18 in total

1.  Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH.

Authors:  Y Dargaud; A S Wolberg; E Gray; C Negrier; H C Hemker
Journal:  J Thromb Haemost       Date:  2017-06-28       Impact factor: 5.824

2.  Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis.

Authors:  Renáta Hudák; Edina G Székely; Katalin R Kovács; Attila Nagy; Gergely Hofgárt; Ervin Berényi; László Csiba; János Kappelmayer; Zsuzsa Bagoly
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

3.  Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations.

Authors:  Rita Carolina Figueiredo Duarte; Cláudia Natália Ferreira; Danyelle Romana Alves Rios; Helton José Dos Reis; Maria das Graças Carvalho
Journal:  Rev Bras Hematol Hemoter       Date:  2017-05-09

4.  Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.

Authors:  Despina Fotiou; Theodoros N Sergentanis; Loula Papageorgiou; Kimon Stamatelopoulos; Maria Gavriatopoulou; Efstathios Kastritis; Theodora Psaltopoulou; Stella Salta; Patrick Van Dreden; Rabiatou Sangare; Annette K Larsen; Evangelos Terpos; Ismail Elalamy; Meletios A Dimopoulos; Grigoris T Gerotziafas
Journal:  Blood Cancer J       Date:  2018-11-07       Impact factor: 11.037

5.  Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application.

Authors:  Jonathan Douxfils; Laure Morimont; Céline Bouvy; Marie de Saint-Hubert; Bérangère Devalet; Célia Devroye; Anne-Sophie Dincq; Jean-Michel Dogné; Maïté Guldenpfennig; Justine Baudar; Anne-Sophie Larock; Sarah Lessire; François Mullier
Journal:  J Thromb Haemost       Date:  2019-05-31       Impact factor: 5.824

6.  ST Genesia reference values of 117 healthy donors measured with STG-BleedScreen, STG-DrugScreen and STG-ThromboScreen reagents.

Authors:  Marisa Ninivaggi; Romy M W de Laat-Kremers; Audrey Carlo; Bas de Laat
Journal:  Res Pract Thromb Haemost       Date:  2020-12-19

7.  Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study.

Authors:  Grigoris T Gerotziafas; Theodoros Zografos; Ioannis Pantos; Eleftheria Lefkou; Audrey Carlo; Jawed Fareed; Patrick Van Dreden; Demosthenes Katritsis
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

8.  Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system.

Authors:  Christian Pfrepper; Michael Metze; Annelie Siegemund; Tristan Klöter; Thomas Siegemund; Sirak Petros
Journal:  Res Pract Thromb Haemost       Date:  2020-04-23

Review 9.  A review of commercially available thrombin generation assays.

Authors:  Jeremy Kintigh; Paul Monagle; Vera Ignjatovic
Journal:  Res Pract Thromb Haemost       Date:  2017-10-16

10.  Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability.

Authors:  Sara Calzavarini; Justine Brodard; Claudia Quarroz; Livia Maire; Raphael Nützi; Jovana Jankovic; Laura C Rotondo; Evelyne Giabbani; Georg Martin Fiedler; Michael Nagler; Anne Angelillo-Scherrer
Journal:  Res Pract Thromb Haemost       Date:  2019-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.